AI assistant
Sending…
Lite Strategy, Inc. — Director's Dealing 2023
Nov 3, 2023
34267_dirs_2023-11-03_b1b595bc-e074-41bf-83b3-78b84697b64e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: MEI Pharma, Inc. (MEIP)
CIK: 0001262104
Period of Report: 2023-10-31
Reporting Person: Flynn James P (N/A)
More from Lite Strategy, Inc.
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
Feb 17
Interim / Quarterly Report
2026
Feb 17
Director's Dealing
2026
Feb 12
Regulatory Filings
2026
Feb 12
Annual Report
2025
Dec 30
Regulatory Filings
2025
Dec 30
Proxy Solicitation & Information Statement
2025
Dec 30
Regulatory Filings
2025
Dec 30